n patients with acute myocardial infarction (AMI), glucose metabolism is modified and stress hyperglycemia is present. Stress hyperglycemia is observed not only in patients with diabetes but also in those without diabetes. An association between plasma glucose level on admission and an increased risk of mortality and poor prognosis after AMI has been reported. 1-4 Whether stress hyperglycemia is causally related to adverse outcomes after AMI is unclear, because of a lack of information in terms of the effect of stress hyperglycemia on myocardial damage following AMI.
With the advent of late gadolinium enhancement (LGE) with cardiac magnetic resonance imaging (CMRI), it is now possible to accurately quantify the extent of myocardial necrosis in vivo. 5 Furthermore, it has been reported that CMRI can demonstrate the myocardial area at risk (AAR), which shows high signal intensity on T2-weighted (T2 W) images as a result of infarct-related edema. 6, 7 Aletras et al established the concept that the area of high T2 signal (edematous myocardium) on CMRI reflects the AAR in reperfused AMI. 8 Thus, comparing the extent of delayed enhancement with the extent of T2 W AAR it is possible to determine the proportion of myocardium that has been salvaged. Clinically, Friedrich et al confirmed that the proportion of myocardial salvage can be assessed in humans using CMRI. 9 The aim of the present study was to examine whether stress hyperglycemia is related to myocardial salvage in patients with AMI. Stress Hyperglycemia and Myocardial Salvage ingness to participate. All patients underwent coronary angiography on admission and then underwent percutaneous coronary intervention (PCI) using coronary stents. All patients were routinely treated with heparin, isosorbide dinitrate, ticlopidine, aspirin, and an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker. Stress hyperglycemia was defined as blood glucose ≥10 mmol/L (180 mg/dl) on admission, as described previously. 10, 11 Patients with a previous or current diagnosis of diabetes or an abnormal oral glucose tolerance test (OGTT, 75-g) 5 days after admission were defined as having diabetes.
Clinical Parameters
The assessed clinical parameters were age, gender, and coronary risk factors (smoking, hypertension, diabetes mellitus, hyperlipidemia, and obesity). The diagnostic criteria for coronary risk factors were as follows. Hypertension: blood pressure ≥140/90 mmHg and/or a history of antihypertensive medication; diabetes mellitus: fasting plasma glucose ≥126 mg/dl, casual plasma glucose ≥200 mg/dl, or a diabetic pattern based on the 75-g OGTT (0 min) >126 mg/dl or OGTT (2 h) >200 mg/dl; hyperlipidemia: serum total cholesterol >220 mg/dl or serum triglyceride >150 mg/dl; obesity: body mass index ≥25 kg/m 2 .
Blood Sampling and Analysis
Venous blood was collected routinely and immediately after admission for plasma glucose determination, before any i.v. medication. Samples were analyzed in the hospital's central laboratory.
Of the 195 study participants, 133 who did not have diabetes were divided on the basis of their admission plasma glucose level into either the normoglycemia group (plasma glucose <180 mg/dl [10 mmol/L]) or the stress hyperglycemia group (plasma glucose ≥180 mg/dl). Similarly, the remaining 62 subjects with diabetes were divided on the basis of their admission plasma glucose level into the same groups (normoglycemia, plasma glucose <180 mg/dl; stress hyperglycemia, plasma glucose ≥180 mg/dl). The 4 groups were compared with regard to baseline and admission characteristics.
Non-Invasive CMRI Protocol
The CMRI was performed using a 1.5-T clinical scanner (Intera Achieva; Philips Medical Systems, Best, The Netherlands) equipped with a 5-element cardiac phased-array coil for signal reception 7 days after the onset of AMI, as previously described. 12-14 During the examination, patients were continuously monitored on single-lead ECG, repeated blood pressure measurements, and pulse oximetry. With the patient in the supine position, contiguous short-axis cine images covering the left ventricle (LV) from base to apex were acquired using a standard steady-state free-precession sequence. We then applied a breath-hold T2 W sequence with short-TI inversion recovery for fat saturation. Imaging parameters were repetition time (TR), 2 R-to-R intervals; echo time (TE), 90 ms; slice thickness, 8 mm; field of view (FOV), 35 μm; matrix, 256×512) in 3 short-axis slices (basal, midventricular, and apical). Each slice was obtained during an end-expiratory breath-hold of 12-15 s depending on the patient's heart rate.
LGE imaging covering the whole ventricle was required 10-15 min after i.v. injection of 0.1 mmol/kg gadolinium diethylenetriamine penta-acetic acid (Gd-DTPA; Magnevist, Schering, Berlin, Germany). We used a 3-D inversion-recovery turbo gradient echo sequence, and images were obtained during an end-expiratory breath-hold. Scan parameters were as follows: TR, 4.1 ms; TE, 1.25 ms; flip angle, 15°; FOV, 350×350 mm; partial echo; matrix, 224×256; and spatial resolution, 1.56×2.24×10 mm 3 reconstructed to 0.68×20.68×5 mm 3 . We optimized the inversion time (200-300 ms) to null the nor- 
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mal myocardium. The slice positions for both T2 W and LGE acquisitions matched those of the cine images.
CMRI Data Analysis
All analyses were performed by consensus of 2 blinded observers (Y.O. and A.S.) on an off-line workstation (View Forum, Philips Medical Systems). The extent of the AAR (T2 W hyperintense lesion) and the extent of the area of LGE were quantified on the same slice location with the maximum extent of T2 signal abnormality using formula as previously reported 9 : (area of high signal/total slice area) ×100. The extent of myocardial salvage 7 days after AMI on CMRI was then defined as the proportion of maximum extent of T2 signal abnormality minus the proportion of LGE in the corresponding section. Myocardial salvage index (MSI) was obtained as follows: extent of myocardial salvage/extent of myocardial AAR ×100. Regional LV function was assessed by determining systolic wall motion in the infarct region. The change of regional wall motion was defined as percent increase of LV wall motion during systole compared with diastole. Myocardial segments showing LGE at day 7 were defined as the infarct region. For an assessment of infarct size, LV myocardium with LGE volumes were quantified. For analysis of the change of regional wall motion, the 2 most basal and 2 most distal slices were excluded, because short-axis images at these levels preclude a reliable segmental evaluation owing to the presence of the LV outflow tract and small diameter, respectively.
Statistical Analysis
All data are expressed as mean ± SD unless stated otherwise. Data were analyzed by comparing a non-diabetic group with a diabetic group. Univariate analysis of differences between the groups was performed using the 2-tailed unpaired t-test and chi-squared or Fisher's exact tests for myocardial salvage variables for the diabetic and non-diabetic groups. P<0.05 were considered significant. A multivariate regression model was used to determine predictors of MSI. Those variables that had P<0.1 on univariate analysis (admission plasma glucose level and reperfusion time) and clinically meaningful factors for MSI (age, sex, hypertension, hyperlipidemia, smoking and obesity) were included in the multivariate logistic analysis. All statistical analysis was done using SPSS version 11.0 (SPSS, Chicago, IL, USA). The authors had full access to the data and take responsibility for its integrity.
Results

Patient Characteristics
Of 195 eligible ST-segment elevation myocardial infarction patients, this study enrolled 150 consecutive patients. The main reasons for exclusion were the lack of CMRI (n=19) and previous myocardial infarction (n=26). Nineteen patients were unable to complete cardiac MRI. Reasons for not undergoing CMRI were difficulties of breath-holding (n=2); arrhythmia (n=2); contrast media allergy (n=1); renal dysfunction (serum creatinine ≥1.5 mg/dl, n=9); and long-term intensive care over 7 days (congestive heart failure, n=2; myocardial rupture, n=2; subacute stent thrombosis, n=1). In all remaining 150 patients, clinical outcome dates were available and CMRI quality was suitable to assess myocardial salvage. On the basis of admission blood glucose level, 81 of the 101 non-diabetic subjects were assigned to the normoglycemia group (<180 mg/dl), and the remaining 20 subjects were assigned to the stress hyperglycemia group (≥180 mg/dl). Of the 49 diabetic subjects, 16 were assigned to the normoglycemia group and 33 to the stress hyperglycemia group.
Characteristics of the non-diabetic and diabetic patients strat- Tables 1,2 , respectively. There were no statistically significant differences in characteristics between the 2 groups without diabetes. Compared with the groups without diabetes, those with diabetes were significantly older and more likely to have hypertension.
Effects of Admission Blood Glucose Level on Acute-Phase MSI
We investigated the relationship between admission blood glucose level and MSI 7 days after AMI. MSI 7 days after AMI was evaluated on CMRI as the difference between the areas of myocardium at risk (T2 W hyperintense lesion) and the areas of LGE (Figure 1) . Evaluation of MSI in a representative nondiabetic patient without stress hyperglycemia and in a representative non-diabetic patient with stress hyperglycemia is shown in Figure 1 . MSI was lower in non-diabetic subjects with stress hyperglycemia than in those without stress hyperglycemia (55.4±13.3% vs. 49.1±10.0%, P=0.047). In subjects with diabetes, no significant association was evident between MSI and glucose level on admission (P=0.422; Figure 2) . On multiple regression analysis, including all variables, stress hyperglycemia appeared to be an independent predictor of MSI in subjects without diabetes (adjusted R 2 =0.053, P=0.046) ( Table 3) . Reperfusion time tended to correlate with MSI, but was not significant (adjusted R 2 =0.61, P=0.084). No other clinical factors affected MSI in subjects without diabetes. In contrast, in subjects with diabetes, stress hyperglycemia did not appear to be an independent predictor of MSI (adjusted R 2 =0.76, P=0.442).
CMRI was performed in 73 patients (non-diabetes, n=54; diabetes, n=19) during the chronic phase 6 months after the onset of AMI. The change of regional wall motion in the chronic phase was correlated with MSI of acute phase (r=0.49, P<0.001; non-diabetes, r=0.45, P=0.001; diabetes, r=0.64, P=0.004; Figure 3 ).
Discussion
We describe herein for the first time the association between impaired MSI and stress hyperglycemia in patients without diabetes on admission for AMI. Although the detailed mechanisms of the association between stress hyperglycemia and the impairment of MSI recovery remain unclear, glycemic status on admission provides important clues for treatment.
Stress hyperglycemia with AMI is associated with an increased risk of in-hospital mortality in patients with and without diabetes. 4 In addition, it has been reported that there is a linear positive relationship between stress hyperglycemia and 
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TERAGUCHI I et al. 15 There is debate as to whether stress hyperglycemia is causally related to impaired LV function after AMI or is simply an epiphenomenon of the severe disease conditions. 16 Interestingly, Ishihara et al showed that there was a significant correlation between higher glucose and impaired predischarge LVEF, even after adjustment for acute LVEF. 17 These finding suggest that stress hyperglycemia may be causally associated with further deterioration of LV function after reperfusion. The present study has demonstrated for the first time that hyperglycemia on admission is an independent predictor of the extent of myocardial salvage in patients without diabetes. Myocardial salvage is the principal mechanism by which patients with AMI benefit from reperfusion therapies. The extent of myocardial salvage is an independent predictor of clinical outcome. 18, 19 In line with these findings, the present study has shown that the changes of regional wall motion index in the chronic phase were correlated with MSI of the acute phase. Therefore, myocardial salvage measurement can be used to determine strategies to optimize management of AMI based on the idea that minimalization is clinically beneficial. Taking these findings together, the assessment of stress hyperglycemia may facilitate identification of appropriate management in patients with recanalized AMI. Further studies on appropriate management in patients with AMI and stress hyperglycemia are warranted. Although we did not address the underlying mechanisms of the relationship between stress hyperglycemia and impairment of myocardial salvage following AMI, both oxidative stress and inflammation may be involved in the process. Oscillating hyperglycemia acutely increases oxidative stress and exaggerates inflammation. It has been reported that circulating levels of cytokines, including interleukin (IL)-6, IL-18, and tumor necrosis factor-α, in subjects with normal or impaired glucose tolerance increased in line with acute increases in blood glucose level. 20 In addition, such cytokine responses to acute elevation of blood glucose were completely inhibited by infusion of the anti-oxidant glutathione. These findings suggest that stress hyperglycemia augments inflammation via oxidative mechanisms closely linked to myocardial salvage. Therefore, we speculate that stress hyperglycemia-induced excessive oxidative stress, leading to inflammation, may result in impairment of myocardial salvage. Further studies are needed to verify this.
In contrast, stress hyperglycemia was not associated with increased impairment of myocardial salvage in AMI patients with diabetes. This may be because the threshold values used to define stress hyperglycemia in individual studies were too low to distinguish between diabetic patients with and without stress hyperglycemia. The definition of stress hyperglycemia is difficult in patients with diabetes because the baseline concentration of glucose is not known. In addition, patients with diabetes are more likely to receive insulin for hyperglycemia during and after AMI. This glycemic control may, to some extent, protect against the additional metabolic stresses associated with AMI.
The efficacy of cardioprotective strategies can be quantified using myocardial salvage as an indicator of therapeutic benefit. Comparing the extent of LGE with the extent of T2 W AAR it is possible to determine the portion of myocardium that has been salvaged. The T1 W and T2 W CMRI approaches for quantification of AAR utilize non-contrast, early and late gadolinium enhancement techniques. The technical progress, high spatial resolution, and potential for retrospective quantification of the AAR make CMRI the most appropriate technique for assessment of myocardial salvage.
Several study limitations should be considered in the interpretation of the results. First, the results were prospective in terms of patient enrollment but observational in nature. Thus, the present study does not provide a mechanistic explanation for the improvement in MSI 7 days after AMI that was associated with stress hyperglycemia on admission. Second, we performed CMRI assessment of MSI 7 days after reperfusion. The time point at which an area of myocardial edema is determined is very important, and it may have an influence on the results. Wright et al evaluated the influence of the time delay between PCI and AAR assessment in patients with reperfused AMI with T2 W CMRI. 13 In their study CMRI was performed between 1 and 20 days after PCI (mean and median 4 days). There was no correlation between T2 W AAR and the delay between PCI and CMRI (r=0.11, P=0.27). They concluded that the delay between PCI and CMRI did not cause systematic differences in the measured T2 W AAR or myocardial salvage. In addition, myocardial edema has been found to be a tissue footprint of the AAR, lasting for at least 7 days after AMI, enabling an extension of the window for assessing myocardial salvage. 21- 23 Bøtker et al recommended that the optimal time to evaluate myocardial salvage within 1 cardiac examination seems to be at 1-2 weeks after infarction, because the extent of the final infarct size on LGE CMRI remains almost constant after 1 week and AAR remains stable for at least 7 days. 23 But we cannot exclude the possibility that earlier data acquisition would have influenced the extent of myocardial salvage. In terms of the optimal timing of measurement of T2 W AAR or myocardial salvage, further serial studies of individual patients are needed.
Conclusions
Stress hyperglycemia in patients without diabetes following AMI may be an important marker for risk stratification while potentially influencing therapeutic strategies.
